Role of inflammatory markers in corona virus disease (COVID-19) patients: a review

J Upadhyay, N Tiwari… - Experimental Biology and …, 2020 - journals.sagepub.com
The whole world is locked down due to the outbreak of novel Coronavirus Disease 2019
(nCOVID-19). A novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

[HTML][HTML] Interleukin 6 and its correlation with COVID-19 in terms of outcomes in an intensive care unit of a rural hospital: a cross-sectional study

D Talwar, S Kumar, S Acharya… - Indian Journal of …, 2022 - ncbi.nlm.nih.gov
Background Interleukin 6 (IL-6) encoded by the gene coded as IL 6 acts as a
proinflammatory cytokine as well as an anti-inflammatory myokine. It is postulated that IL 6 is …

Immunity and inflammatory biomarkers in COVID‐19: a systematic review

APD Iwamura, MR Tavares da Silva… - Reviews in Medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …

Targeting cytokine storm to manage patients with COVID-19: a mini-review

N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …

Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study

A Tufa, TH Gebremariam, T Manyazewal… - Frontiers in …, 2022 - frontiersin.org
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may
represent disease severity. We aimed to assess plasma inflammatory mediator …

Cytokine storm in COVID-19: immunopathogenesis and therapy

C Zanza, T Romenskaya, AC Manetti, F Franceschi… - Medicina, 2022 - mdpi.com
A cytokine storm is a hyperinflammatory state secondary to the excessive production of
cytokines by a deregulated immune system. It manifests clinically as an influenza-like …

Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19

W Sayah, I Berkane, I Guermache, M Sabri, FZ Lakhal… - Cytokine, 2021 - Elsevier
Accumulating evidence supports that the viral-induced hyper-inflammatory immune
response plays a central role in COVID-19 pathogenesis. It might be involved in the …

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019

T Liu, J Zhang, Y Yang, H Ma, Z Li, J Zhang… - EMBO molecular …, 2020 - embopress.org
Progression to severe disease is a difficult problem in treating coronavirus disease 2019
(COVID‐19). The purpose of this study is to explore changes in markers of severe disease in …

A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients

MS Soltani-Zangbar, F Parhizkar, E Ghaedi… - Cell Communication and …, 2022 - Springer
Background The COVID-19 pandemic has become the world's main life-threatening
challenge in the third decade of the twenty-first century. Numerous studies have been …

Cytokine profile and disease severity in patients with COVID-19

A Ghazavi, A Ganji, N Keshavarzian, S Rabiemajd… - Cytokine, 2021 - Elsevier
Cytokine dysregulation is the proposed mechanism for Coronavirus disease 2019 (COVID-
19). The aim of this study was to evaluate the serum levels of interferon (IFN)-γ, interleukin …